Archit Organosys Limited disclosed its un-audited financial results for the quarter and half year ended September 30, 2026, pursuant to Regulation 30 read with Schedule III and Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Financial Performance Highlights

Quarter Ended September 30, 2026 (Q2 FY27):

  • Revenue from Operations: ₹6,399.46 lakhs (₹63.99 crore)
  • Other Income: ₹63.62 lakhs
  • Total Income: ₹6,463.08 lakhs (₹64.63 crore)
  • Profit Before Tax: ₹189.58 lakhs (₹1.90 crore)
  • Tax Expense: ₹35.21 lakhs
  • Net Profit: ₹154.37 lakhs (₹1.54 crore)
  • Basic and Diluted EPS: ₹0.75

Half Year Ended September 30, 2026 (H1 FY27):

  • Revenue from Operations: ₹10,107.70 lakhs (₹101.08 crore)
  • Other Income: ₹124.05 lakhs
  • Total Income: ₹10,231.75 lakhs (₹102.32 crore)
  • Profit Before Tax: ₹392.70 lakhs (₹3.93 crore)
  • Tax Expense: ₹93.63 lakhs
  • Net Profit: ₹299.07 lakhs (₹2.99 crore)
  • Basic and Diluted EPS: ₹1.46

Comparative Performance

Quarterly Comparison (Q2 FY27 vs Q2 FY26):

  • Revenue increased from ₹3,285.99 lakhs to ₹6,399.46 lakhs (94.8% growth)
  • Net Profit remained relatively stable: ₹154.37 lakhs vs ₹153.92 lakhs

Half-Year Comparison (H1 FY27 vs H1 FY26):

  • Revenue increased from ₹6,605.55 lakhs to ₹10,107.70 lakhs (53.0% growth)
  • Net Profit decreased from ₹357.51 lakhs to ₹299.07 lakhs (16.3% decline)

Financial Position as of September 30, 2026

Assets:

  • Total Assets: ₹13,107.36 lakhs (₹131.07 crore)
  • Non-current Assets: ₹6,227.85 lakhs
  • Current Assets: ₹6,879.51 lakhs
  • Property, Plant and Equipment: ₹4,620.43 lakhs
  • Trade Receivables: ₹3,943.53 lakhs
  • Cash and Cash Equivalents: ₹107.61 lakhs

Liabilities and Equity:

  • Total Equity: ₹7,923.32 lakhs
  • Equity Share Capital: ₹2,052.07 lakhs (face value ₹10 per share)
  • Other Equity: ₹5,871.25 lakhs
  • Total Liabilities: ₹5,184.04 lakhs
  • Current Borrowings: ₹490.32 lakhs
  • Non-current Borrowings: ₹230.93 lakhs

Cash Flow Statement (Half Year Ended September 30, 2026)

  • Net Cash from Operating Activities: ₹855.89 lakhs
  • Net Cash from Investing Activities: ₹950.94 lakhs
  • Net Cash used in Financing Activities: ₹(1,836.63) lakhs
  • Net Decrease in Cash: ₹(29.80) lakhs

Key Notes and Disclosures

Segment Information: The Company operates in a single segment - "Chemicals and Organics" as per Ind AS 108.

Labour Codes Implementation: The Company assessed the impact of newly notified Central Rules under Labour Codes and concluded there is no material financial impact. The Company continues to monitor finalization of State Rules.

Subsidiaries: The Company does not have any subsidiary, associate, or joint venture companies.

Board Meeting Details: The meeting was held on November 04, 2026, commencing at 3:40 PM and ending at 4:00 PM.

Auditor Review: The financial results were reviewed by G K Choksi & Co., Chartered Accountants, who issued a limited review report with no material misstatements identified.

Regulatory Compliance: The results were prepared in accordance with Ind AS 34 and Regulation 33 of SEBI Listing Regulations.